Differential response to amlodipine and atenolol mono-therapy for hypertension by ethnic group.
Kirby
P L
PL
Department of General Practice and Primary Care, Queen Mary and Westfield College, Mile End Road, London E1 4NS, UK. P.L.Kirby@mds.qmw.ac.uk
Caulfield
M C
MC
Collier
D J
DJ
Eldridge
S
S
Griffiths
C G
CG
Hemingway
H
H
Poulter
N R
NR
Feder
G S
GS
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D001741:Black or African American; D017311:Amlodipine / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use*; D018660:Blood Pressure Monitoring, Ambulatory; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D005006:Ethnicity; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000208:ethnology*; D016015:Logistic Models; D008297:Male; D015337:Multicenter Studies as Topic; D012083:Renin / Q000172:deficiency; D011795:Surveys and Questionnaires; D044465:White People
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D017311:Amlodipine; D001262:Atenolol; D012083:Renin